Medexus Pharmaceuticals Inc.

TSX:MDP 주식 보고서

시가총액: CA$59.9m

Medexus Pharmaceuticals 과거 수익 실적

과거 기준 확인 1/6

Medexus Pharmaceuticals은 연평균 30.8%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 수입이 증가했으며, 연간 46%였습니다. 매출은 연평균 18.7%의 비율로 증가했습니다. Medexus Pharmaceuticals의 자기자본이익률은 3.4%이고 순이익률은 1%입니다.

주요 정보

30.8%

수익 성장률

33.7%

EPS 성장률

Pharmaceuticals 산업 성장23.1%
매출 성장률18.7%
자기자본 수익률3.4%
순이익1.0%
다음 실적 업데이트07 Nov 2024

최근 과거 실적 업데이트

There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Aug 19
There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Recent updates

There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Aug 19
There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 10
Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth

Jul 31
Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth

The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Jun 15
The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Apr 25
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Mar 03
Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Jan 06
Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Oct 11
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 11
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Jan 19
Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 22
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Dec 16
Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Aug 21
Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Aug 04
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

수익 및 비용 분석

Medexus Pharmaceuticals 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

TSX:MDP 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 241091431
31 Mar 241130452
31 Dec 231166462
30 Sep 231195473
30 Jun 231173483
31 Mar 231081483
31 Dec 22100-11473
30 Sep 2292-11463
30 Jun 22822444
31 Mar 2277-3446
31 Dec 2174-8447
30 Sep 2177-20437
30 Jun 2177-31406
31 Mar 2180-28365
31 Dec 2079-19333
30 Sep 2069-9312
30 Jun 2064-7312
31 Mar 2056-5311
31 Dec 1947-4311
30 Sep 1945-3290
30 Jun 1936-6220
31 Mar 1925-5160
31 Dec 1817-5100
30 Sep 189-560
30 Jun 188-260
31 Mar 188-360
31 Dec 178-360
30 Sep 177-360
30 Jun 176-360
31 Mar 175-150
31 Dec 164150
30 Sep 163150
30 Jun 163150
31 Mar 163-250
31 Dec 153-450
30 Sep 152-450
30 Jun 152-560
31 Mar 152-460
31 Dec 143-460
30 Sep 143-450
30 Jun 144-350
31 Mar 143-350
31 Dec 134-240

양질의 수익: MDP 에는 $2.3M 큰 일회성 손실이 있습니다. $2.3M 은 지난 12개월 간의 재무 결과에 30th June, 2024 까지 영향을 미쳤습니다.

이익 마진 증가: MDP 의 현재 순이익 이익률 (1%) 작년보다 낮습니다 (2.8%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: MDP 지난 5년 동안 수익을 창출하여 매년 30.8% 수익을 올렸습니다.

성장 가속화: MDP 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: MDP 은 지난 1년 동안 마이너스 수익 성장( -66.6% )을 기록하여 Pharmaceuticals 업계 평균( -40.8% ).


자기자본 수익률

높은 ROE: MDP 의 자본 수익률( 3.4% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기